General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Treasury Stock
Series A Preferred Stock
Treasury Stock
Additional Paid-in Capital
Series A Preferred Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Income) Loss Net of Income Taxes
Series A Preferred Stock
Total
Balance at Dec. 31, 2017 $ 140           $ 280,051 $ 8,004     $ 288,195
Balance (in shares) at Dec. 31, 2017 139,528                    
Foreign currency translation adjustment                 $ 3   3
Stock-based compensation             1,442       1,442
Common stock issued under employee purchase plan             100       100
Common stock issued under employee purchase plan (in shares) 50                    
Common stock issued upon exercise of stock options             7       $ 7
Common stock issued upon exercise of stock options (in shares) 2                   2
RSU Vested (in shares) 38                    
Net income               3,177     $ 3,177
Balance at Dec. 31, 2018 $ 140           281,600 11,181 3   292,924
Balance (in shares) at Dec. 31, 2018 139,618                    
Foreign currency translation adjustment                     (67)
Foreign currency translation adjustment                 (70)   (70)
Stock-based compensation             1,680       1,680
Common stock issued upon exercise of stock options             177       $ 177
Common stock issued upon exercise of stock options (in shares) 65                   65
RSU Vested (in shares) 38                    
Net income               23,307     $ 23,307
Balance at Dec. 31, 2019 $ 140           283,457 34,488 (67)   318,018
Balance (in shares) at Dec. 31, 2019 139,721                    
Foreign currency translation adjustment                 (153)   (153)
Stock-based compensation             802       802
Common stock issued upon exercise of stock options             70       70
Common stock issued upon exercise of stock options (in shares) 32                    
Net income               2,440     2,440
Balance at Mar. 31, 2020 $ 140           284,329 36,928 (220)   321,177
Balance (in shares) at Mar. 31, 2020 139,753                    
Balance at Dec. 31, 2019 $ 140           283,457 34,488 (67)   318,018
Balance (in shares) at Dec. 31, 2019 139,721                    
Foreign currency translation adjustment                     488
Net income                     12,323
Balance at Sep. 30, 2020 $ 140           287,825 46,811 421   335,197
Balance (in shares) at Sep. 30, 2020 139,935                    
Balance at Dec. 31, 2019 $ 140           283,457 34,488 (67)   318,018
Balance (in shares) at Dec. 31, 2019 139,721                    
Foreign currency translation adjustment                 1,078   1,078
Stock-based compensation             5,984       5,984
Exchange of common stock for Series A preferred stock   $ 454   $ (260,686)   $ 260,232          
Exchange of common stock for Series A preferred stock (in shares)   45,438   15,146              
Issuance of stock   $ 156       $ 85,308       $ 85,464  
Issuance of stock (in shares)   15,568                  
Repurchase of vested options             (15,506)       (15,506)
Common stock issued under employee purchase plan             424       424
Common stock issued under employee purchase plan (in shares) 61                    
Common stock issued upon exercise of stock options             780       $ 780
Common stock issued upon exercise of stock options (in shares) 255                   254
RSU Vested (in shares) 185                    
Net income               20,453     $ 20,453
Balance at Dec. 31, 2020 $ 140   $ 610   $ (260,686)   620,679 54,941 1,011   416,695
Balance (in shares) at Dec. 31, 2020 140,222   61,006   15,146            
Balance at Mar. 31, 2020 $ 140           284,329 36,928 (220)   321,177
Balance (in shares) at Mar. 31, 2020 139,753                    
Foreign currency translation adjustment                 231   231
Stock-based compensation             1,140       1,140
Common stock issued upon exercise of stock options             51       51
Common stock issued upon exercise of stock options (in shares) 58                    
Net income               4,078     4,078
Balance at Jun. 30, 2020 $ 140           285,520 41,006 11   326,677
Balance (in shares) at Jun. 30, 2020 139,811                    
Foreign currency translation adjustment                 410   410
Stock-based compensation             1,619       1,619
Common stock issued under employee purchase plan             423       423
Common stock issued under employee purchase plan (in shares) 61                    
Common stock issued upon exercise of stock options             263       263
Common stock issued upon exercise of stock options (in shares) 44                    
RSU Vested (in shares) 19                    
Net income               5,805     5,805
Balance at Sep. 30, 2020 $ 140           287,825 46,811 421   335,197
Balance (in shares) at Sep. 30, 2020 139,935                    
Balance at Dec. 31, 2020 $ 140   $ 610   $ (260,686)   620,679 54,941 1,011   416,695
Balance (in shares) at Dec. 31, 2020 140,222   61,006   15,146            
Foreign currency translation adjustment                 (799)   (799)
Stock-based compensation             2,538       2,538
Common stock issued upon exercise of stock options             538       538
Common stock issued upon exercise of stock options (in shares) 180                    
Net income               5,644     5,644
Balance at Mar. 31, 2021 $ 140   $ 610   $ (260,686)   623,755 60,585 212   424,616
Balance (in shares) at Mar. 31, 2021 140,402   61,006   15,146            
Balance at Dec. 31, 2020 $ 140   $ 610   $ (260,686)   620,679 54,941 1,011   416,695
Balance (in shares) at Dec. 31, 2020 140,222   61,006   15,146            
Foreign currency translation adjustment                     $ (141)
Common stock issued upon exercise of stock options (in shares)                     1,710
Net income                     $ 1,000
Balance at Sep. 30, 2021 $ 159       $ (1,802)   677,588 55,941 870   732,756
Balance (in shares) at Sep. 30, 2021 158,524       50            
Balance at Mar. 31, 2021 $ 140   $ 610   $ (260,686)   623,755 60,585 212   424,616
Balance (in shares) at Mar. 31, 2021 140,402   61,006   15,146            
Foreign currency translation adjustment                 355   355
Stock-based compensation             4,714       4,714
Exchange of common stock for Series A preferred stock $ 5   $ (610)   $ 260,686   (260,081)        
Exchange of common stock for Series A preferred stock (in shares) 5,190   (61,006)   (15,146)            
Common stock issued upon exercise of stock options $ 2           2,907       2,909
Common stock issued upon exercise of stock options (in shares) 871                    
RSU Vested (in shares) 217                    
Net income               (12,568)     (12,568)
Balance at Jun. 30, 2021 $ 158           670,674 48,017 567   719,416
Balance (in shares) at Jun. 30, 2021 157,768                    
Foreign currency translation adjustment                 303   303
Stock-based compensation             4,848       4,848
Common stock issued upon exercise of stock options $ 1           2,066       2,067
Common stock issued upon exercise of stock options (in shares) 651                    
RSU Vested (in shares) 105                    
Net income               7,924     7,924
Balance at Sep. 30, 2021 $ 159       $ (1,802)   $ 677,588 $ 55,941 $ 870   $ 732,756
Balance (in shares) at Sep. 30, 2021 158,524       50